Dubai’s healthcare ecosystem is undergoing a significant transformation, driven by the integration of AI to enhance personalised care. 

Spearheaded by the Dubai Health Authority (DHA), as part of The Emirati Genome Programme, the initiative is being executed in Dubai by G42 Healthcare, in collaboration with DHA setting the stage for a new era of medicine, The Programme aims to build the first de novo Emirati reference genome, based on the DNA of UAE nationals. 

This will allow scientists, researchers and medical experts to understand the unique genetic make-up of Emiratis, which will help establish the foundation for innovation in health and wellness in the Dubai, providing a rich database that AI can utilise to tailor treatments to individual genetic profiles. 

This initiative is a critical component of Dubai’s broader vision to become a global leader in healthcare innovation, positioning the city as a pioneer in personalised medicine.